How Important Is Controlling Risk Factors for the Prevention of a Stroke?

How Important Is Controlling Risk Factors for the Prevention of a Stroke?There has been a recent decline of about 20% to 40% in the incidence of cerebrovascular accidents (stroke). Although this is attributed to the improvement of risk factor control, the reason behind it is not utterly clear. This study estimated the impact of modifiable cardiovascular risk factors on the incidence of stroke between 1995 and 2012.

 

The risk of ischemic stroke was estimated by proportional regression among 26,329 participants in the register. The estimate was adjusted for unmodifiable risk factors such as age and gender.

 

There were 1226 new stroke cases per 36,7636 person-years of follow-up. Changes in risk factors accounted for 57% of the decrease in the incidence of this event from 1995 to 2012. The two factors that contributed the most to incidence decrease were systolic blood pressure (decreased by 26%) and smoking prevalence (decreased by 17%). Conversely, increasing diabetes prevalence contributed negatively to stroke incidence.

 

Conclusion

Changes in cardiovascular risk factors accounted for 57% of the decrease in stroke incidence. Reduction in systolic blood pressure and prevalence of smoking were the most important contributors.

 

Original title: Declining Incidence of Ischemic Stroke. What Is the Impact of Changing Risk Factors? The Tromso Study 1995 to 2012.

Reference: Anne M. Vangen-Lonne et al. Stroke. 2017 Feb 10. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...